True about aplastic anemia –
**Question:** True about aplastic anemia -
A. Aplastic anemia is caused by a deficiency of stem cell production.
B. It is a rare condition affecting fewer than 1% of the population.
C. Symptoms include easy bruising and fatigue.
D. Treatment involves only supportive care and symptomatic relief.
**Correct Answer:** .
**Core Concept:** Aplastic anemia is a rare blood disorder characterized by a deficiency in the production of blood cells in the bone marrow. This deficiency results from a variety of factors, including genetic mutations, viral infections, and exposure to certain chemicals or medications. In aplastic anemia, the bone marrow fails to produce sufficient numbers of red blood cells, white blood cells, and platelets, leading to symptoms like fatigue, easy bruising, and increased susceptibility to infections.
**Why the Correct Answer is Right:** Aplastic anemia is indeed caused by a deficiency of stem cell production, which is the primary mechanism underlying this condition. This deficiency is typically due to factors such as genetic mutations or exposure to toxic substances. The condition affects a larger number of people than the statement claims (it can affect individuals of all ages), but it is still relatively rare compared to other hematological disorders.
**Why Each Wrong Option is Incorrect:**
A. Aplastic anemia is not primarily caused by a deficiency of stem cell production. It is caused by factors affecting stem cell function or survival, as explained above.
B. While aplastic anemia can affect individuals of all ages, the prevalence is not as low as 1% of the population. It is a rare but not extremely rare condition.
C. The symptoms of aplastic anemia can vary, but fatigue and easy bruising are common findings. Fatigue is a result of anemia due to decreased red blood cell production, while easy bruising can occur due to decreased platelet production and/or dysfunction.
D. Treatment for aplastic anemia involves both supportive care and hematopoietic stem cell transplantation (HSCT) in severe cases. HSCT is often effective in restoring blood cell production, but supportive care includes transfusions, antibiotics, and sometimes antiviral therapy if caused by infections.
**Clinical Pearl:** Aplastic anemia is a complex condition that requires a comprehensive approach to management. Treatment involves supportive care to manage symptoms and complications, as well as HSCT in severe cases. Proper diagnosis and management are crucial to prevent complications and improve patient outcomes. Early recognition and intervention are vital, as untreated or inadequately treated aplastic anemia can lead to severe complications like infections, bleeding, and organ failure.